Journal of Oncology Research and Treatment
Open Access
Metastatic Cancer
Search results for
Metastatic Cancer
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 31
Journal of Oncology Research and Treatment received 31 citations as per Google Scholar report
Journal of Oncology Research and Treatment peer review process verified at publons
Indexed In
- Google Scholar
- RefSeek
- Hamdard University
- EBSCO A-Z
- Publons
- ICMJE
Useful Links
Share This Page
Metastatic Cancer
Metastatic cancer is cancer that has spread from the place where it first started to another place in the body. A tumor formed by metastatic cancer cells is called a metastatic tumor or a metastasis. The process by which cancer cells spread to other parts of the body is also called metastasis.
Related Journals of Metastatic cancer
Advances in Cancer Research, Oncologist, Molecular Cancer Research, Gastric ancer, Blood Reviews, British Journal of Cancer, European Journal of Cancer, International journal of Cancer
Metastatic Cancer
Expert PPTs
- Jun Yang
Histopathology and pathogenesis of digestive system and Female genital and breast tumors
PPT Version | PDF Version - He Wang
Cytopathology
PPT Version | PDF Version - Dr. Sarfraz Ahmad
- Lonnie Zeltzer
Dr. Lonnie Zeltzer, Director, Distinguished Professor of Pediatrics, Anesthesiology, Psychiatry and Biobehavioral Sciences
PPT Version | PDF Version - Aruna Turaka
Intensity modulated radiation therapy
PPT Version | PDF Version - Hosam A Elbaz
Characterization of the pharmacological effects of cardiac glycosides on lung epithelial cells
PPT Version | PDF Version - You Mie Lee
Cell signalling and Biochips
PPT Version | PDF Version
Speaker PPTs
- Rongtuan Lin
Modulating the Antioxidant Defences to Potentiate Oncolytic Virotherapy in Refractory Cancer Cells
PPT Version | PDF Version - Ganapathi Bhat Mugulthimoole
Unmasking the masquerading cancer cells: have we made progress with the revival of immunotherapy?
PPT Version | PDF Version - Moshe Giladi
Tumor Treating Fields (TTFields) induced cancer cell death may be immunogenic resulting in enhanced antitumor efficacy when combined with immune-modulating therapy
PPT Version | PDF Version - Ping Yang
Chronic obstructive pulmonary disease (COPD) complicating early-stage lung cancer (LC)
| PDF Version - Daniel S Peiffer
Dietary consumption of black raspberries or their anthocyanin constituents alters innate immune cell trafficking in esophageal cancer
| PDF Version - Afsar Rahbar
Studies of the importance of Cytomegalovirus infection in breast cancer
PPT Version | PDF Version - Mervi Siekkinen
Effect of e-feedback on knowledge about radiotherapy of breast cancer patients
PPT Version | PDF Version - Inge Verbrugge
Radio-immunotherapy of cancer: Therapeutic efficacy, underlying mechanisms and potential applications
PPT Version | PDF Version - Carolina Alonso-González
Melatonin sensitizes human breast cancer cells to ionizing radiation
PPT Version | PDF Version - Guldeniz Karadeniz Cakmak
The importance of intraoperative ultrasound guidance to achieve negative margins for palpable and nonpalpable breast cancer
PPT Version | PDF Version - Sribatsa Kumar Mahapatra
Triple ABC Technique in Clinical Assessment in Breast Cancer Diagnosis
PPT Version | PDF Version - Daisuke Ota
The clinical outcome of reconstruction with tissue expander for breast cancer patients with mastectomy
PPT Version | PDF Version - Nicolae Bacalbasa
The benefits of surgery for breast cancer liver metastases â a single center experience
PPT Version | PDF Version - Ozlem Tokusoglu
Phenolics and Cancer
| PDF Version - Sitanshu Sekhar Lahiri
A novel oral formulation for cancer therapy, loaded in a slow release matrix for targeted delivery
PPT Version | PDF Version - Stefan B Eichmüller
Identification of CD4+ T cell epitopes specific for the breast cancer associated antigen NY-BR-1
| PDF Version - Thomas Kieber-Emmons
Developing a first in man carbohydrate mimetic peptide vaccine for cancer: A translational story
| PDF Version - Yi-Cheng Hu
Detection of a negative correlation between prescription of Chinese herbal products containing coumestrol, genistein or daidzein and risk of subsequent endometrial cancer among tamoxifentreated female breast cancer survivors in Taiwan between 1998 and 2008: A population-based study
PPT Version | PDF Version - Daniel H. Snyder
Breast cancer in young age (â¤40 years): The University of Tennessee Medical Center at Knoxville 10 year experience
PPT Version | PDF Version - Mieke Van Hemelrijck
A role for lipids and statins in breast cancer risk and prevention?
PPT Version | PDF Version - Piwen Wang
Enhanced chemopreventive effect by combining Quercetin and green tea in prostate cancer
| PDF Version - Gaspar Banfalvi
Origin of breast cancer metastasis
PPT Version | PDF Version - San Ming Wang
Unknown genetic predisposition in familial breast cancer can lie deep in family tree
PPT Version | PDF Version - Vicente Marco
Changes in breast cancer pathology reports after second opinion
PPT Version | PDF Version - Christopher Busby
The breast cancer epidemic: Evidence for a radiogenic cause
PPT Version | PDF Version - Saroj Velamakanni
Multiparameter analysis using cell cycle biomarkers for breast cancer: Prognostic and predictive implications
PPT Version | PDF Version - Benjamin Y. M. Yung
A Big Data Analysis Platform to Unveil Gene Interactions in Cancer
PPT Version | PDF Version - Jalal Poorolajal
The effect of body mass index on endometrial cancer: A meta-analysis
PPT Version | PDF Version - Tatiana V Macfarlane
Aspirin use and risk of Head and Neck Cancer: evidence from the INHANCE consortium
PPT Version | PDF Version - Babak Behnam
SLUG and SOX9 Cooperatively Regulate Tumor Initiating Niche Factors in Breast Cancer
PPT Version | PDF Version - Yosef Yarden
Classically, the 3âuntranslated region (3âUTR) is that region in eukaryotic protein-coding genes from the translation termination codon to the polyA signal. It is transcribed as an integral part of the mRNA encoded by the gene. However, there exists another kind of RNA, which consists of the 3âUTR alone, without all other elements in mRNA such as 5âUTR and coding region. The importance of independent 3âUTR RNA (referred as I3âUTR) was prompted by results of artificially introducing such RNA species into malignant mammalian cells. Since 1991, we found that the middle part of the 3âUTR of the human nuclear factor for interleukin-6 (NF-IL6) or C/EBP gene exerted tumor suppression effect in vivo. Our subsequent studies showed that transfection of C/EBP 3âUTR led to down-regulation of several genes favorable for malignancy and to up-regulation of some genes favorable for phenotypic reversion. Also, it was shown that the sequences near the termini of the C/EBP 3âUTR were important for its tumor suppression activity. Then, the C/EBP 3âUTR was found to directly inhibit the phosphorylation activity of protein kinase CPKC in SMMC-7721, a hepatocarcinoma cell line. Recently, an AU-rich region in the C/EBP 3âUTR was found also to be responsible for its tumor suppression. Recently we have also found evidence that the independent C/EBP 3âUTR RNA is actually exists in human tissues, such as fetal liver and heart, pregnant uterus, senescent fibroblasts etc. Through 1990âs to 2000âs, world scientists found several 3âUTR RNAs that functioned as artificial independent RNAs in cancer cells and resulted in tumor suppression. Interestingly, majority of genes for these RNAs have promoter-like structures in their 3âUTR regions, although the existence of their transcribed products as independent 3âUTR RNAs is still to be confirmed. Our studies indicate that the independent 3âUTR RNA is a novel non-coding RNA species whose function should be the regulation not of the expression of their original mRNA, but of some essential life activities of the cell as a whole.
PPT Version | PDF Version - Suoqin Tang
Survivin siRNA nano particles are capable of inhibiting liver cancer cell growth both in vitro and in vivo
PPT Version | PDF Version - Eli Raveh
From chromosomal instability to metastases- H19âs role in cancer progression and its clinical significance
PPT Version | PDF Version - Hugo Albrecht
Towards pharmacological validation of MNKs as anti-cancer drug targets
PPT Version | PDF Version - Wei Duan
Cancer stem cells targeted delivery of siRNA to overcome induced chemoresistance
PPT Version | PDF Version - Lourdes Cortes Dericks
Cancer Stem Cell Markers in Lung Cancer: Proofs of Concept and Some Reservations
PPT Version | PDF Version - Huidi Liu
Reduced Expression of SOX7 in Ovarian Cancer: a Novel Tumor Suppressor through the Wnt/β-catenin Signaling Pathway
PPT Version | PDF Version - Isabelle De Waziers
Use of engineered mesenchymal stem cells against cancers
PPT Version | PDF Version - Soha M Hamdy
Biochemical studies on the effect of turmeric on breast cancer of rats
PPT Version | PDF Version - Maria da Graça Justo Araujo
Fanconi anemia: Immune deficiency and susceptibility to cancer
PPT Version | PDF Version - Pi-Wan Cheng
Disregulation of Golgi localization of glycosyltransferases alters mucin O-glycosylation and survival or metastatic properties of cancer cells
PPT Version | PDF Version - Sourav Sarkar
MUC1 glycopeptide based anti-cancer vaccines
PPT Version | PDF Version - Medhat Faris
Patient advocacy program for breast cancer patients in the eastern province
PPT Version | PDF Version - Jose Roberto Piato
Improved frozen section examination of the retroareolar margin for prediction of nipple involvement in breast cancer
PPT Version | PDF Version - Ewa Maj
Antiangiogenic treatment in non-small cell lung cancer (NSCLC)
PPT Version | PDF Version - James A Bonner
Anti-EGFr monoclonal antibody therapy in Head and Neck cancer
PPT Version | PDF Version - Francis Mussai
Tumour arginine addiction subverts the anti-cancer immune response
PPT Version | PDF Version - Saif Uddin Ahmed
Breast Cancer: Presentation & limitation oftreatment - Bangladesh perspective
PPT Version | PDF Version - Punit Kaur
A Mouse Model for Triple-Negative Breast Cancer Stem Cells (TNBC-CSC) Exhibits an Aggressive Phenotype
PPT Version | PDF Version - Matthew Curzon, M.D.
Breast cancer in elderly patients (70 years and older): The University of Tennessee Medical Center at Knoxville 10 year experience
PPT Version | PDF Version - Heather Gage
HER2+ breast cancer: Pre and post adjuvant anti-HER2 therapy era - the University of Tennessee Medical Center at Knoxville 11 year experience
PPT Version | PDF Version - Peter Weightman
A new approach to the diagnosis of cervical, oesophageal and prostate cancer based on a combination of infrared and terahertz techniques
PPT Version | PDF Version - Fabienne Meier-Abt
Mechanisms of Early Pregnancy-Mediated Breast Cancer Protection
PPT Version | PDF Version - Federico Cattin
Breast cancer: A comparison among different diagnostic and therapeutic protocols
PPT Version | PDF Version - Lei Huo
Diagnostic biomarkers in metastatic breast cancer
PPT Version | PDF Version - Shareef Alqahtani
Illitracy and Breast Cancer Screening Utilization: A Case Study of Saudi Women over 60 Years of Age
PPT Version | PDF Version - Arghya Adhikary
PEGylated-thymoquinone-nanoparticle mediated retardation of breast cancer cell migration by deregulation of cytoskeletal actin polymerization through miR-34a
PPT Version | PDF Version - Amila Orucevic
Prognostic value of ER, PR, and HER2 breast cancer biomarkers and AJCCâs TNM staging system on overall survival of Caucasian females with breast cancer: An institutionâs 10 year experience
PPT Version | PDF Version - Phillip K. Darcy
Cancer immunotherapy utilizing gene-modified T cells: from the bench to the clinic.
PPT Version | PDF Version - Yvonne Paterson
HER-2/neu as a target forListeria-based cancer immunotherapy for breast cancer
PPT Version | PDF Version - Caigang Liu
FSIP1: A new potential early screening marker for breast cancer
PPT Version | PDF Version - Domenico Samorani
Screening of Breast Cancer from Mammography to MR Imaging
PPT Version | PDF Version - Diptendra K Sarkar
Role of NFKB as a prognostic marker in breast cancer: a new tool in the horizon
PPT Version | PDF Version - S Karthikeyan
Resveratrol modulates expression of ABC transporters in non-small lung cancer cells: Molecular docking and gene expression studies
PPT Version | PDF Version - Sushmita Pathy
Role of Radiotherapy in Multidisciplinary Management of Rectal Cancers
PPT Version | PDF Version - Dashrath Ram N Reddy
Role of Nutraceuticals in chemoprevention and cancer treatment
PPT Version | PDF Version - Praveen Kumar Saxena
Metal Burden -Cancer
PPT Version | PDF Version - Pravin D Potdar
Molecular Profiling of Cancer Cells
PPT Version | PDF Version - Shaqul Qamar Wani
Cervical Cancer: An update on the guidelines for screening
PPT Version | PDF Version - Amany Mohammed Shebl
Impact of nursing management protocol on radiotherapy induced git side effects (nausea, vomiting, and diarrhea) in patients with cancer
PPT Version | PDF Version - Kevin Carvalho de Melo Faria
Laparoscopic Gastrectomy for Gastric Cancer Treatment: Report of an Initial Experience
PPT Version | PDF Version - Peiying Yang
Role of Na, K-ATPase in Gastrointestinal Cancer
PPT Version | PDF Version - Almas Okassov
Chemical modification of anticancer Parasporins for decreasing of their toxicity
PPT Version | PDF Version - Alvaro Ronco
Nutriequalization: Attempting to improve survival in cancer patients through nutritional modifications
PPT Version | PDF Version - Antonio Cilla
Antiproliferative effect of main dietary phytosterols and/or β-cryptoxanthin in human colon cancer Caco-2 cells through cytosolic Ca2+ - and oxidative stress-induced apoptosis
PPT Version | PDF Version - Vineeta Deshmukh
Effectiveness of Ayurvedic treatment in alleviating side-effects of radiotherapy in oropharyngeal cancer patients and its relationship with improvement in immune status of the host
PPT Version | PDF Version - Mingsong Wu
Identification of differentially expressed genes in human lung adenocarcinoma: ERGIC3 as a novel lung cancer-related gene
PPT Version | PDF Version - Dean A
Identifying physical and psycho-social issues facing breast cancer survivors after definitive treatment for early breast cancer: a nurse-led clinic model
PPT Version | PDF Version - SinYoung Kim
Health beliefs and breast cancer screening among Korean immigrant women
PPT Version | PDF Version - Shulamith Kreitler
Where, when and how to die: Insights into issues of critical nursing in cancer
PPT Version | PDF Version - Liselotte Jakobsson
Does a salutogenic attitude increase life quality after prostate cancer treatment?
PPT Version | PDF Version - Adriana Katz
Na,K-ATPase isoform-selective cardiac glycosides- a potential anti-cancer drug ?
PPT Version | PDF Version - Tamar Geiger
Genome-Scale Proteomic Profiling of Breast Cancer Progression
PPT Version | PDF Version - Chien-Fu Hung
Mark cancer cells for CTL attack through coating with viral antigenic peptides CTLs kill tumor with viral peptides
PPT Version | PDF Version - Rahul Purwar
Engineered T cells: Next-generation cancer immunotherapy
PPT Version | PDF Version - John A. Barrett
Localized regulated expression of IL-12 as a gene therapy approach to cancer immunotherapy
PPT Version | PDF Version - Tao Lu
Using VBIM technique to identify drug resistance genes in ovarian cancer
PPT Version | PDF Version - Lydia Benhocine
Cancers, chemotherapies and hemodialysis: A retrospective study
PPT Version | PDF Version - RanjitaPallavi
Geriatric Oncology: Caring for the older patient with cancer
PPT Version | PDF Version - Lourdes Cortes-Dericks
ALDHhigh/CD44+ putative cancer stem cell population as therapeutic target in malignant pleural mesothelioma
PPT Version | PDF Version - Mark D Gorrell
The protease fibroblast activation proteinas a biomarker and therapeutic target in cancer and chronic liver injury
PPT Version | PDF Version - Daniel Rotroff
Using DNA copy number aberrations in naturally occurring canine cancers to identify candidate drivers of carcinogenesis
PPT Version | PDF Version - Ivan Mfouo-Tynga
Effects of SulfonatedZinc Phthalocyanine and Low Intensity Laser Irradiation in Inducing Photodynamic Damagein Breast Cancer Cells
| PDF Version - Mark Kester
Nanocolloidsfor Cancer
PPT Version | PDF Version - Yajun Yi
Meta-analysis of transcriptional profiles in cancer for prognosis prediction and metastatic gene identification
PPT Version | PDF Version - Vladimir Pak
Double Targeting as an Effective Anti-Cancer Strategy
PPT Version | PDF Version - Luminita Castillos
Gene expression profiling for targeted cancer treatment
PPT Version | PDF Version - Anton Yuryev
Construction of cancer pathways for personalized medicine
PPT Version | PDF Version - Jung-Joon Min
Bacteria-mediated expression of cargo drugs and reporter gene for cancer-specific theranostics
| PDF Version - Maria Paola COSTI
A proteomic-bioinformatic integrated approach for studying the effect of a peptide drug candidate on ovarian Cancer
PPT Version | PDF Version - Bing Zhang
Translating multidimensional cancer omics data into biological insights
PPT Version | PDF Version - Vladimir Torchilin
Stimuli-sensitive combination nanopreparations of siRNA and chemotherapeutic drugs to treat multidrug resistant cancer
PPT Version | PDF Version - Kelvin K. Tsai
Linking tissue microarchitectures to rationalized molecular diagnostics in glandular cancers
PPT Version | PDF Version - Zuping Xia
Development of Sphingosine Kinase Inhibitors for Cancer Therapy
PPT Version | PDF Version - Charles F. L. Mbakaya
Elucidating the link between environment, nutrition, host immunity, AIDS and cancer as informed by selected studies in Kenya and beyond
PPT Version | PDF Version